Medicinal product Emoxipin®
Pharmacotherapeutic group
Capillary stabilizers.
Code ATX CO5C X
Content
Active substance: methylethylpyridinol hydrochloride; 1 ml of solution contains methylethylpyridinol hydrochloride 10 mg;
Excipients: diluted hydrochloric acid, water for injections.
Medicinal form
Solution for injections.
Indications
Subconjunctival and intraocular hemorrhage of various genesis. Angioretinopathy (including diabetic retinopathy). Central and peripheral choreoretinal dystrophy. Thrombosis of the central retinal vein and its branches. Complicated myopathy. Angiosclerotic macular dystrophy (cyxa form). Detachment of the choroid in patients with glaucoma in the postoperative period. Dystrophic diseases of the cornea. Injuries, burns of the cornea. Protection of the cornea (when using contact lenses) and the retina from high-intensity light (sun rays, laser radiation during laser coagulation).
Contraindication
Increased individual sensitivity to the drug. Method of administration and dosage Emoxipin solution is administered subconjunctivally or parabulbarally. If necessary, retrobulbar injection is possible. 0.2-0.5 ml (2-5 mg) of a 1% solution is administered subconjunctivally, 0.5-1 ml (5-10 mg) parabulbarally. The drug is used for 10-30 days once a day or every other day.
For more detailed information, read the instructions